Is a complete NSE/BALPHARMA research report available?

No complete published report is available for nse/BALPHARMA (NSE/BALPHARMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/BALPHARMA stock profile: metrics, valuation and analysis

Market cap	1.5B
Revenue (ttm)	3.3B
Net income (ttm)	72.1M
EPS (ttm)	₹4.50
P/E (trailing)	21.0x
Dividend	₹1.20 (1.37%)
Volume	126,041
Beta	0.45

All NSE/BALPHARMA indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

INR

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	939
Employees Change	-47%
Employees Change Percent	-4.77
Enterprise value	INR 3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.65
Industry PE Fwd	33.99
Isin	INE083D01012
Last refreshed	2026-09-09
Market cap	INR 1.5B
Price	INR 95.38
Price currency	INR
Rev Per Employee	3,561,304.58x
Sector	Healthcare
Sector PE	47.97
Sector PE Fwd	38.43
Sic	2834
Symbol	nse/BALPHARMA
Website	https://www.balpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.76%
EV Earnings	41.84x
EV/EBIT	13.43x
EV/EBITDA	8.65x
EV/FCF	24.55x
EV/Sales	0.9x
FCF yield	8.12%
P/B ratio	1.84x
P/E ratio	20.99x
P/S ratio	0.45x
PE Ratio10 Y	39.91x
PE Ratio3 Y	24.77x
PE Ratio5 Y	30.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.71%
EBITDA Margin	10.42%
FCF margin	3.94%
Gross margin	47.5%
Gross Profit	INR 1.6B
Gross Profit Growth	11.67%
Gross Profit Growth Q	15.89%
Gross Profit Growth3 Y	5.82%
Gross Profit Growth5 Y	9.26%
Net Income	INR 72.1M
Net Income Growth	0.69%
Net Income Growth Q	460.07%
Net Income Growth Qo Q	-68.74%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	44.8%
Net Income Growth5 Y	3.93%
Pretax Margin	2.05%
Profit Margin	2.16%
Profit Per Employee	INR 76,747
Profitable Quarters	INR 25
Profitable Years	6
Roa5y	3.79
Roe5y	8.61
ROIC	9.51
Roic5y	7.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.86%
Cagr15y	10.94%
Cagr1y	9.4%
Cagr20y	6.07%
Cagr3y	-0.6%
Cagr5y	0.69%
Div CAGR10	1.84%
Div CAGR3	6.27%
Div CAGR5	3.71%
EPS Growth	-1.66
EPS Growth Q	446.2
EPS Growth Qo Q	-68.58
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	38.64
EPS Growth5 Y	1.76
FCF Growth	248.22%
FCF Growth5 Y	-8.33%
OCF Growth	51.79%
OCF Growth10 Y	7.81%
OCF Growth5 Y	6.66%
Revenue Growth	13.51x
Revenue Growth Q	34.53x
Revenue Growth Qo Q	5.4x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	3.14x
Revenue Growth5 Y	4.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 92.9M
Debt	INR 1.6B
Debt EBITDA	INR 4.58
Debt Equity	INR 1.94
Debt FCF	INR 12.99
Equity	INR 822.5M
Interest Coverage	1.3
Net Cash	INR -1.5B
Net Cash By Market Cap	INR -99.3
Net Debt EBITDA	INR 4.31
Net Debt Equity	INR 1.83
Net Debt FCF	INR 12.23
Tangible Book Value	INR 649.8M
Tangible Book Value Per Share	INR 40.87
WACC	7.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.39%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 1.2
Dividend Years	6
Dividend Yield	1.37%
Ex Div Date	2026-09-17
Last Dividend	INR 1.2
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	20.21%
1Y total return	9.4%
200-day SMA	78.28
3Y total return	-1.78%
50-day SMA	85.99
50-day SMA vs 200-day SMA	50over200
5Y total return	3.5%
All Time High	167.9
All Time High Change	-43.19%
All Time High Date	2016-01-13
All Time Low	13
All Time Low Change	633.69%
All Time Low Date	2013-06-21
ATR	3.83
Beta	0.45
Ch YTD	30.09
High	97.6
High52	98.85
High52 Date	2026-05-27
High52ch	-3.51%
Low	93
Low52	60
Low52 Date	2026-03-30
Low52ch	58.97%
Ma50ch	10.91%
Price vs 200-day SMA	21.84%
RSI	70.73
RSI Monthly	52.64
RSI Weekly	64.82
Sharpe ratio	0.26x
Sharpe Ratio3y	0.16x
Sharpe Ratio5y	0.17x
Sortino ratio	0.57
Sortino Ratio3y	0.4
Sortino Ratio5y	0.43
Total Return	-1.02%
Tr YTD	30.09
Tr15y	374.28%
Tr1m	6.89%
Tr1w	12.21%
Tr3m	10.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,462,081%
Net Borrowing	91,361,000
Shares Insiders	52.16%
Shares Qo Q	-0.48%
Shares Yo Y	2.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	27,422.3x
Bv Per Share	51.71
CAPEX	INR -185.5M
Ch10y	8.14
Ch15y	294.9
Ch1m	6.89
Ch1w	12.21
Ch1y	7.93
Ch20y	146.5
Ch3m	10.61
Ch3y	-4.95
Ch5y	-1.77
Ch6m	31.61
Change	2.9%
Change From Open	1.71
Close	92.69
Days Gap	1.18
Depreciation Amortization	124,104,500
Dollar Volume	12,021,790.6
Earnings Date	2026-08-12
EBIT	INR 224.5M
EBITDA	INR 348.6M
EPS	INR 4.5
F Score	3
FCF	INR 122.8M
FCF EV Yield	4.07x
Financing CF	-95,864,000
Fiscal Year End	March
Founded	1,987
Graham Number	72.81204
Graham Upside	-23.66
Income Tax	INR -3.9M
Investing CF	-206,994,000
Is Primary Listing	0
Last Earnings Date	2026-08-12
Last Report Date	2026-06-30
Lynch Fair Value	INR 22.72
Lynch Upside	-76.18
Ma150	80.12
Ma150ch	19.05%
Ma20	86.85
Ma20ch	9.83%
Net CF	5,495,000
Next Earnings Date	2026-11-14
Open	93.78
P FCF Ratio	12.32
P OCF Ratio	4.91
Payment Date	2026-10-24
Position In Range	51.74
Price Date	2026-09-08
Price EBITDA	INR 4.34
Ptbv Ratio	2.33
Relative Volume	5.44x
Revenue	3,344,065,000x
Tax By Revenue	-0.12x
Tr20y	224.96%
Tr6m	31.61%
Volume	126,041

NSE/BALPHARMA (NSE/BALPHARMA)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/BALPHARMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/BALPHARMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/BALPHARMA

Frequently asked questions